oHCM

1 stories · following the connections

Business

MyoKardia Announces Positive Results from Low-Dose Cohort of Phase 2 PIONEER-HCM Study of Mavacamten in Symptomatic, Obstructive Hypertrophic Cardiomyopathy Patients

By Nasdaq OMXMar 8, 2018, 9:02 PM UTC